We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Induced Pluripotent Stem Cells Flourish in Novel 3D Culture System

By LabMedica International staff writers
Posted on 26 Jan 2016
Stem cell researchers have developed a three-dimensional (3D) gel-based culture system that optimizes production of induced pluripotent stem cells (iPSCs).

iPSCs are derived from mature, adult cells that have been genetically reprogrammed to revert to a stem cell-like state. More...
These cells can then be reprogrammed to grow and mature into a wide range of different cell types. Since the discovery of iPSCs, numerous approaches have been explored to improve the original protocol, which is based on a two-dimensional cell-culture system. Surprisingly, nothing was known about the effect of a more biologically faithful 3D environment on somatic-cell reprogramming.

To fill this gap in stem cell knowledge investigators at Ecole Polytechnique Fédérale de Lausanne (Switzerland) analyzed how reprogramming of somatic cells occurred within engineered three-dimensional extracellular matrices. By modulating stiffness, degradability, and biochemical composition of a gel-based microenvironment, they identified a previously unknown role for biophysical effectors in the promotion of iPSC generation.

They reported in the January 11, 2016, online edition of the journal Nature Materials that the physical cell confinement imposed by the 3D microenvironment boosted reprogramming through an accelerated mesenchymal-to-epithelial transition and increased epigenetic remodeling.

"We try to simulate the three-dimensional environment of a living tissue and see how it would influence stem cell behavior," said senior author Dr. Matthias P. Lutolf, head of the laboratory of stem cell bioengineering at Ecole Polytechnique Fédérale de Lausanne. "But soon we were surprised to see that cell reprogramming is also influenced by the surrounding microenvironment. Each cell type may have a "sweet spot" of physical and chemical factors that offer the most efficient transformation. Once you find it, it is a matter of resources and time to create stem cells on a larger scale."

The investigators pointed out that their 3D culture protocol could be readily scaled up to produce stem cells for various applications on an industrial scale.

Related Links:

Ecole Polytechnique Fédérale de Lausanne



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
POC Immunoassay Analyzer
Procise DX
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.